Antimicrobial therapy in exacerbated chronic obstructive pulmonary disease;Uso de antimicrobianos en la exacerbación de la enfermedad pulmonar obstructiva crónica

Archivos de Bronconeumologia

Volumn 38, Issue 2, 2002, Pages 81-89

  Alvarez F ^a   Bouza, E ^b   Garcia Rodriguez J A ^b   Mayer, M A ^c   Mensa, J ^b   Monso E ^a   Nodar, E ^c   Picazo, J J ^b   Sobradillo, V ^a   Torres, A ^a  

^a Sociedad Española de Neumología Y Cirugía Torácica SEPAR   (Spain)

^b Sociedad Española de Quimioterapia SEQ   (Spain)

^c Sociedad Española de Medicina Familiar y Comunitaria SEMFYC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; AZITHROMYCIN; BETA LACTAM ANTIBIOTIC; BRONCHODILATING AGENT; CEFEPIME; CEFOTAXIME; CEFTRIAXONE; CIPROFLOXACIN; CLARITHROMYCIN; CORTICOSTEROID; GLUCOCORTICOID; IMIPENEM; LEVOFLOXACIN; MACROLIDE; MEROPENEM; MOXIFLOXACIN; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TOBRAMYCIN;

ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ANTIMICROBIAL THERAPY; ARTICLE; CHLAMYDOPHILA PNEUMONIAE; CHRONIC BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE EXACERBATION; DYSPNEA; FORCED EXPIRATORY VOLUME; HAEMOPHILUS INFLUENZAE; HOSPITALIZATION; HUMAN; MORAXELLA CATARRHALIS; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS; STREPTOCOCCUS PNEUMONIAE; TREATMENT INDICATION;

EID: 0036124381     PISSN: 03002896     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-2896(02)75157-0     Document Type: Article

References (58)

1. The definition of emphysema: Report of the National Heart and Blood Institute, division of lung diseases, workshop
2. Tratamiento antibiótico empírico inicial de la neumonía adquirida en la comunidad
3. Europe and tobacco
4. Geographic variations in prevalence and underdiagnosis of COPD. Results of the IBERPOC Multicentre Epidemiological study
5. Prospective study of aetiology and outcome of adult lower respiratory tract infections in the community
6. Use of investigations in lower respiratory tract infection in the community: A European survey
7. Initial antibiotic therapy for lower respiratory tract infection in the community: A European survey
8. Estudio de las infecciones respiratorias extrahospitalarias
9. Relationship between bacterial flora in sputum and functional impairment in patients with acute exacerbations of COPD
10. Infective exacerbations of chronic bronchitis. Relation between bacteriologic etiology and lung function
11. Bacterial infection in chronic obstructive pulmonary disease. A study of stable and exacerbated outpatients using the protected specimen brush
12. Bronchial microbial patterns in severe exacerbations of chronic obstructive pulmonary disease (COPD) requiring mechanical ventilation
13. Association of indoor and outdoor particulate pollution level with chronic respiratory illness
14. The UCLA population studies of chronic obstructive pulmonary disease. XI. Impact of air pollution and smoking on annual change in forced expiratory volume in one second
15. Lung function testing: Selection of reference values and interpretative strategies
16. Guía clínica para el diagnóstico y tratamiento de la enfermedad pulmonar obstructiva crónica
17. When can an exacerbation of COPD be treated at home?
18. A randomized trial of nocturnal oxygen therapy in chronic obstructive pulmonary disease patients
19. Outcomes following acute exacerbations of severe chronic obstructive lung disease
20. Use of emergency medical services by patients with decompensated obstructive lung disease
21. Spirometric criteria for hospital admission of patients with acute exacerbation of COPD
22. Predictive factors of hospitalization for acute exacerbation in a series of 64 patients with chronic obstructive pulmonary disease
23. Comparison of clinical dysnea ratings and psychophysical measurementes of respiratory sensation in obstructive airways disease
24. Characterization of distal bronchial microflora during acute exacerbations of chronic bronchitis: Use of the protected specimen brush technique in 54 mechanically ventilated patients
25. Bacterial colonization of distal airways in healthy subjects and chronic lung disease: A bronchoscopic study
26. Management of community acquired pneumonia in the era of pneumococcal resistance: A report from drug-resistant Streptococcus pneumoniae
27. Evaluation of antimicrobial treatment in patients with severe exacerbations of chronic pulmonary disease
28. Prospective study of the usefulness of Gram stain in the initial approach to community-acquired pneumonia requiring hospitalization
29. Bronchitis and asthma
30. Safety and efficacy of temafloxacin versus ciprofloxacin in lower respiratory tract infections: A randomized, double-blind trial
31. Acute infective exacerbations of chronic bronchitis
32. Etiology, susceptibility and treatment of acute bacterial exacerbations for complicated chronic bronchitis in the primary care setting: Ciprofloxacin 750 mg b.i.d. versus clarithromycin 500 mg b.i.d.
33. Sparfloxacin vs ofloxacin in the treatment of acute exacerbations of chronic bronchitis: A multicenter, double-blind, randomized, comparative study
34. The Spanish Surveillance group: Antimicrobial resistance of 1,113 Streptococcus pneumoniae isolates from patients with respiratory tract infections in Spain: Results of a 1 year (1996-1997) multicenter surveillance study
35. Pseudomonas aeruginosa: A survey of resistance in 136 hospitals in Spain
36. The bacteriology of chronic bronchitis
37. Diagnosis of bacterial pulmonary infections with quantitative protected catheter cultures obtained during bronchoscopy
38. Characterization of distal bronchial microflora during acute exacerbation of chronic bronchitis. Use of the protected specimen brush technique in 54 mechanically ventilated patients
39. El cepillado protegido bacteriológico en pacientes con EPOC severa
40. Haemophilus influenzae in chronic bronchitis
41. Bacterial infection in chronic obstructive pulmonary disease
42. Reduction in the incidence of acute bronchitis by an oral Haemophilus influenzae vaccine in patients with chronic bronchitis in the highlands of Papua New Guinea
43. A controlled trial of a killed Haemophilus influenzae vaccine for prevention of acute exacerbations of chronic bronchitis
44. Oral immunization with killed Haemophilus influenzae for protection against acute bronchitis in chronic obstructive lung disease
45. Protection against recurrent acute bronchitis after oral immunization with killed Haemophilus influenzae
46. Haemophilus influenzae oral vaccination against acute bronchitis
47. Studies on P6, an important outer-membrane protein antigen of Haemophilus influenzae
48. Enhanced respiratory clearance of nontypeable Haemophilus influenzae following mucosal immunization with P6 in a rat model
49. Prevention of pneumococcal disease: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
50. Pneumococcal vaccines. WHO position paper
51. Vaccin anti-pneumococcique: Justifications et resultats
52. Role of infection in chronic bronchitis
53. Infections with viruses and Mycoplasma pneumoniae during exacerbations of chronic bronchitis
54. Association of viral and Mycoplasma pneumoniae infections with acute respiratory illness in patients with chronic obstructive pulmonary diseases
55. Bronchial microbial patterns in severe exacerbations of chronic obstructive pulmonary disease (COPD) requiring mechanical ventilation
56. Influenza vaccine for patients with chronic obstructive pulmonary disease (Cochrane review)
57. Effectiveness of influenza vaccine in reducing hospital admissions during the 1989-90 epidemic
58. Purpose of quality standards for infectious diseases